Cargando…
Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer
Since its first approval by the FDA in 2017, tremendous progress has been made in chimeric antigen receptor (CAR) T cell therapy, the adoptive transfer of engineered, CAR-expressing T lymphocyte. CAR T cells are all composed of three main elements: an extracellular antigen-binding domain, an intrace...
Autores principales: | Ma, Hong Yun, Das, Jeeban, Prendergast, Conor, De Jong, Dorine, Braumuller, Brian, Paily, Jacienta, Huang, Sophia, Liou, Connie, Giarratana, Anna, Hosseini, Mahdie, Yeh, Randy, Capaccione, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670348/ https://www.ncbi.nlm.nih.gov/pubmed/37998743 http://dx.doi.org/10.3390/cimb45110566 |
Ejemplares similares
-
Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer
por: de Jong, Dorine, et al.
Publicado: (2023) -
More than Just Skin-Deep: A Review of Imaging’s Role in Guiding CAR T-Cell Therapy for Advanced Melanoma
por: Prendergast, Conor M., et al.
Publicado: (2023) -
Advances in PET/CT Imaging for Breast Cancer
por: de Jong, Dorine, et al.
Publicado: (2023) -
Translating Molecules into Imaging—The Development of New PET Tracers for Patients with Melanoma
por: Vercellino, Laetitia, et al.
Publicado: (2022) -
The Clinical Utility of Molecular Imaging in COVID-19: An Update
por: Elsakka, Ahmed, et al.
Publicado: (2023)